COVALENT-102: A phase 1/1b dose finding study of BMF-219, an oral covalent menin inhibitor, in adults with locally advanced, unresectable, or metastatic non-small cell lung cancer (NSCLC), pancreatic cancer (PDAC) and colorectal cancer (CRC) with...

Autor:	Fountzilas, Christos, Cohen, Stacey A., Duvivier, Herbert Leon, Hong, David S., Pedersen, Katrina Sophia, Pisick, Evan P., Sommerhalder, David, Cacovean, Alex, Follit, Courtney, Kowalczyk, Nicole, Munneke, Brian, Tong, Tracy, Morris, Steve, Butler, Thomas, Spira, Alexander I.
Zdroj:	Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, pTPS716-TPS716, 117p
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu